[On toxoplasmosis].
D006801:Humans; D011379:Prognosis; D011739:Pyrimethamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology
D011743:Pyrimidines; D013449:Sulfonamides; D011739:Pyrimethamine
Considerazioni sulla toxoplasmosi.